Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts
Author:
Funder
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
http://link.springer.com/content/pdf/10.1007/s40264-016-0491-0.pdf
Reference51 articles.
1. Deyo R. Gaps, tensions, and conflicts in the FDA approval process: implications for clinical practice. J Am Board Fam Med. 2004;17(2):142–9.
2. Smith CC, Bennet PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol. 1996;42:423–9.
3. Brownstein JS, Freifeld CC, Madoff LC. Digital disease detection—harnessing the Web for public health surveillance. N Engl J Med. 2009;360(21):2153–7. doi: 10.1056/NEJMp0900702 .
4. Brown D. 52 Cool facts about social media--2012 edition dannybrown.me. 2012. http://dannybrown.me/2012/06/06/52-cool-facts-social-media-2012 . Accessed 6 Oct 2015.
5. Beevolve. An exhaustive study of Twitter users across the world--social media analytics. Beevolve. 2012. http://temp.beevolve.com/twitter-statistics/-cl . Accessed 6 Oct 2015.
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estimating Patient Satisfaction Through a Language Processing Model: Model Development and Evaluation;JMIR Formative Research;2023-09-14
2. The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives;Drug Design, Development and Therapy;2023-09
3. Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database;Cancers;2023-07-19
4. Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data;Current Oncology;2023-06-20
5. All-round approaches to increase adverse drug reaction reports: a scoping review;Drugs & Therapy Perspectives;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3